GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 117 filers reported holding GENERATION BIO CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,506,927 | -31.8% | 397,606 | -1.0% | 0.00% | 0.0% |
| Q2 2023 | $2,208,107 | +32.6% | 401,474 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $1,665,317 | +11.7% | 387,283 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $1,491,297 | -24.5% | 379,465 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $1,975,000 | +2892.4% | 371,942 | +3591.0% | 0.00% | – |
| Q2 2022 | $66,000 | +46.7% | 10,077 | +63.1% | 0.00% | – |
| Q1 2022 | $45,000 | -94.2% | 6,177 | -94.3% | 0.00% | – |
| Q4 2021 | $774,000 | +67.2% | 109,327 | +535.0% | 0.00% | – |
| Q2 2021 | $463,000 | -40.2% | 17,217 | -36.7% | 0.00% | – |
| Q1 2021 | $774,000 | +38600.0% | 27,185 | +55379.6% | 0.00% | – |
| Q3 2020 | $2,000 | -91.7% | 49 | -95.7% | 0.00% | – |
| Q2 2020 | $24,000 | – | 1,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |